Tiha M. Long, Ph.D. - Publications
Affiliations: | 2014 | Molecular Medicine | University of Maryland School of Medicine, Baltimore, MD, United States |
Area:
Molecular Biology, Microbiology BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2018 | Long TM, Tonsing-Carter EY, Chan W, Griend DV, Conzen SD, Szmulewitz RZ. Abstract 944: Glucocorticoid receptor (GR)-mediated activation of cyclic-adenosine monophosphate (cAMP) pathway gene expression following androgen receptor (AR) antagonism of prostate cancer Cancer Research. 78: 944-944. DOI: 10.1158/1538-7445.Am2018-944 | 0.338 | |||
2017 | Kach J, Long TM, Selman P, Tonsing-Carter EY, Bacalao MA, Lastra RR, de Wet L, Comiskey S, Gillard M, VanOpstall C, West DC, Chan WC, Vander Griend D, Conzen SD, Szmulewitz RZ. Selective glucocorticoid receptor modulators (SGRMs) delay castrate-resistant prostate cancer growth. Molecular Cancer Therapeutics. PMID 28428441 DOI: 10.1158/1535-7163.Mct-16-0923 | 0.345 | |||
2014 | Long TM, Nisa S, Donnenberg MS, Hassel BA. Enteropathogenic Escherichia coli inhibits type I interferon- and RNase L-mediated host defense to disrupt intestinal epithelial cell barrier function. Infection and Immunity. 82: 2802-14. PMID 24733098 DOI: 10.1128/Iai.00105-14 | 0.584 | |||
2013 | Long TM, Chakrabarti A, Ezelle HJ, Brennan-Laun SE, Raufman JP, Polyakova I, Silverman RH, Hassel BA. RNase-L deficiency exacerbates experimental colitis and colitis-associated cancer. Inflammatory Bowel Diseases. 19: 1295-305. PMID 23567782 DOI: 10.1097/Mib.0B013E318281F2Fd | 0.606 | |||
2013 | Long TM, Chakrabarti A, Ezelle H, Brennan-Laun S, Raufman J, Polyakova I, Silverman R, Hassel B. Abstract 2863: RNase-L modulates the immune response to intestinal damage and ameliorates murine colitis and colitis-associated cancer. Cancer Research. 73: 2863-2863. DOI: 10.1158/1538-7445.Am2013-2863 | 0.61 | |||
Show low-probability matches. |